The GLP-1 wave is no longer coming — it’s here. With demand surging, pipelines evolving, and new challengers emerging, the weight loss therapeutics landscape is undergoing a seismic shift.
In the inaugural HLTH Edge Webinar, our analysts break down the strategic and clinical developments that matter most right now — and what they signal for the future of care, access, and investment.
You’ll learn:
Who’s winning the GLP-1 race — and what the next generation of competitors is bringing to market
Pricing and reimbursement dynamics that will define patient access and payer strategies
The high-stakes impact of compounding, oral delivery formats, and adherence trends across populations
GLP-1s are rewriting the playbook on obesity treatment.
